Relief Therapeutics Holding AG (RLFTF)

[mc67]

$RLFTF (related) About HHS, ASPR, and BARDA:

HHS works to enhance and protect the health and well-being of all Americans, providing for effective health and human services and fostering advances in medicine, public health, and social services.

The mission of ASPR is to save lives and protect Americans from 21st century health security threats. Within ASPR, BARDA invests in the innovation, advanced research and development, acquisition, and manufacturing of medical countermeasures (MCMs) – vaccines, drugs, therapeutics, diagnostic tools, and non-pharmaceutical products needed to combat health security threats.

To date, BARDA-supported MCMs have achieved 56 FDA approvals, licensures or clearances.

For more on BARDA’s portfolio for COVID-19 diagnostics, vaccines and treatments and about partnering with BARDA, visit medicalcountermeasures.gov.

To learn more about federal support for the all-of-America COVID-19 response, visit coronavirus.gov.

https://www.quantumleaphealth.org/media/hhs-dod-engage-quantum-leap-healthcare-collaborative-in-search-for-effective-treatments-for-the-sickest-covid-19-patients?fbclid=IwAR0_i1hu7WpVPCwyEZmrMyOjQ0nqqzBpcUcOFKuZVPPMddbVwYUoWtSkwLY